Global Transplantation Market to Surge to $30.1 Billion by 2030

NEW YORK - Oct. 7, 2024 - PRLog -- The transplantation market generated $13,605.9 million in revenue and is expected to reach $30,117.5 million by 2030, growing at a rate of 9.2% from 2021 to 2030. This expansion is driven by the rising cases of chronic conditions such as solid tumors, kidney failure, plasma cell disorders, myelodysplastic syndromes, and immune system disorders.

Additionally, the increasing awareness about organ donation, along with technological advancements like robot-assisted kidney transplants, has boosted the industry's growth. The success of organ transportation and the significant use of tissue products in orthobiologics for orthopedic procedures also play key roles.

Tissue products are expected to maintain a dominant position in the industry, thanks to their growing application in procedures that restore normal function, promote tissue healing, and reduce pain, particularly for an aging population. Moreover, immunosuppressive drugs are forecast to grow at the fastest rate (9.6%), driven by a rising incidence of autoimmune disorders such as multiple sclerosis, alopecia areata, and arthritis, along with organ failure in the kidneys, liver, heart, and lungs.

The growing disposable incomes in emerging economies are further driving the demand for immunosuppressive drugs. Tissue transplantation holds a strong share of the market, generating over 60% of revenue, with the transplantation of skin, blood vessels, bones, heart valves, tendons, ligaments, and corneas becoming more common. Skin grafting is a widely used procedure, fueled by increased burn cases, road accidents, and skin cancer.

Browse detailed report analysis on "Transplantation Market Growth and Forecast Report, 2030 (https://www.psmarketresearch.com/market-analysis/transpla...)"

Organ transplantation is also set for steady growth, driven by unhealthy dietary habits and reduced physical activity, as well as national efforts to raise awareness and improve regulation around organ donation. Hospitals account for about 50% of the industry's revenue, positioning themselves as major centers for both organ and tissue transplantation due to advancements in healthcare infrastructure and well-established donor databases.

Transplantation centers are also significant contributors, driven by increasing awareness among both patients and donors about their specialized services and expertise. These centers also play a key role in research and development, contributing to advancements in transplantation procedures.

North America dominates the market, with 40% of the global share, and the U.S. leads the region due to a large number of patients requiring organ transplants—particularly for kidneys, liver, pancreas, heart, and lungs. Increased R&D efforts in healthcare are boosting the success rates of such procedures.

In summary, the rising prevalence of chronic diseases is a major factor driving the growth of the transplantation market, alongside increasing demand for organ transplantation.